Generation Bio reported a net loss of $14.8 million for Q1 2025, an improvement from the $74.5 million net loss in Q1 2024. The company's cash position remains strong at $157.6 million, expected to fund operations into the second half of 2027, and it continues to advance its cell-targeted lipid nanoparticle (ctLNP) technology for autoimmune diseases.

Kronos Worldwide, Inc. reported a net loss of $13.2 million, or $0.12 per share, in the fourth quarter of 2024. This was primarily due to increased income tax expense, including non-cash deferred income tax expenses related to currency translation gains and losses and a valuation allowance on Belgian net deferred tax assets. Despite the net loss, income from operations increased significantly due to higher sales and production volumes and lower production costs.

Kronos Worldwide, Inc. reported a net income of $71.8 million, or $.62 per share, in the third quarter of 2024, a significant improvement compared to a net loss of $20.4 million, or $.18 per share, in the third quarter of 2023. The increase was primarily due to higher income from operations, resulting from increased sales and production volumes, and lower production costs, partially offset by lower average TiO2 selling prices. Net sales increased by 22% compared to the same period in 2023, driven by higher sales volumes due to strengthening demand for TiO2.

Kronos Worldwide, Inc. reported a net income of $19.5 million, or $.17 per share, in the second quarter of 2024, compared to a net loss of $8.2 million, or $.07 per share, in the second quarter of 2023. Net sales increased by 13% to $500.5 million. The company's TiO2 segment profit was $41.1 million, a significant improvement from the $2.3 million loss in the same quarter last year.

Kronos Worldwide reported a net income of $8.1 million, or $0.07 per share, for the first quarter of 2024, compared to a net loss of $15.2 million, or $0.13 per share, for the first quarter of 2023. Net sales for the first quarter of 2024 were $478.8 million, an increase of 12% compared to the first quarter of 2023.

Kronos Worldwide, Inc. reported a net loss of $5.3 million in Q4 2023, compared to a net loss of $19.9 million in Q4 2022. Net sales were $400.1 million, a 17% increase from Q4 2022, driven by higher sales volumes in Europe and North America, despite lower average TiO2 selling prices.

Kronos Worldwide, Inc. reported a net loss of $20.4 million, or $.18 per share, in the third quarter of 2023, compared to a net income of $21.0 million, or $.18 per share, in the third quarter of 2022. The decrease in net income was primarily due to lower income from operations, resulting from lower sales volumes and average TiO2 selling prices.

Kronos Worldwide, Inc. reported a net loss of $8.2 million, or $.07 per share, in the second quarter of 2023 compared to net income of $45.9 million, or $.40 per share, in the second quarter of 2022. Net sales were $443.2 million in the second quarter of 2023, a decrease of 22% compared to the second quarter of 2022. The results were impacted by reduced demand and changes in currency exchange rates.

Kronos Worldwide, Inc. reported a net loss of $15.2 million, or $.13 per share, for Q1 2023, a significant decrease compared to the net income of $57.5 million, or $.50 per share, in Q1 2022. The decline was primarily due to lower sales volumes, higher production costs, and the impact of currency exchange rates.

Kronos Worldwide, Inc. reported a net loss of $19.9 million, or $.18 per share, in Q4 2022, compared to a net income of $31.6 million, or $.28 per share, in Q4 2021. Net sales were $342.4 million, a decrease of 31% compared to Q4 2021. The TiO2 segment experienced a loss of $15.0 million, compared to a profit of $55.6 million in the same quarter of the previous year.

Kronos Worldwide reported a decrease in net income for the third quarter of 2022 compared to the same period in 2021, primarily due to lower income from operations. This was a result of higher production costs, lower sales volumes, and higher average TiO2 selling prices. Net sales also decreased due to lower sales volumes in European, export, and North American markets, despite higher average TiO2 selling prices.

Kronos Worldwide, Inc. reported a significant increase in net income for the second quarter of 2022, rising to $45.9 million, or $.40 per share, compared to $25.7 million, or $.22 per share, in the second quarter of 2021. Net sales also increased to $565.3 million, up 18% from the second quarter of 2021, driven primarily by higher average TiO2 selling prices.

Kronos Worldwide reported a significant increase in net income for Q1 2022, driven by higher average TiO2 selling prices and increased sales volumes. Net sales also increased, although were negatively impacted by currency exchange rates.

Kronos Worldwide reported a strong fourth quarter in 2021, with net income increasing to $31.6 million and net sales rising to $496.0 million, primarily driven by higher average TiO2 selling prices. The company's TiO2 segment profit also saw a significant increase compared to the same period in 2020.

Kronos Worldwide, Inc. reported a significant increase in net income for Q3 2021, reaching $36.0 million, or $.31 per share, compared to $8.1 million, or $.07 per share, in Q3 2020. The increase was primarily driven by higher sales volumes and average TiO2 selling prices, although partially offset by increased production costs.

Kronos Worldwide reported net sales of $478.6 million and net income of $25.7 million for the second quarter of 2021. Net sales increased due to higher sales volumes and higher average TiO2 selling prices. Net income increased due to higher income from operations.

Kronos Worldwide reported first quarter 2021 results with net sales increasing by 10% to $465.0 million, driven by higher sales volumes. However, net income decreased to $19.6 million, or $.17 per share, due to lower income from operations.

Kronos Worldwide, Inc. reported net income of $10.2 million, or $.09 per share, in the fourth quarter of 2020 compared to net income of $9.4 million, or $.08 per share, in the fourth quarter of 2019. Net sales of $414.9 million in the fourth quarter of 2020 were $42.2 million, or 11%, higher than in the fourth quarter of 2019.

Kronos Worldwide reported a decrease in net income for Q3 2020, with net income at $8.1 million, or $0.07 per share, compared to $17.9 million, or $0.16 per share, in Q3 2019. The decrease was primarily due to lower sales volumes and lower average TiO2 selling prices, partially offset by lower production costs.

Kronos Worldwide, Inc. reported a decrease in net income for the second quarter of 2020, with net income at $18.6 million, or $.16 per share, compared to $29.5 million, or $.25 per share, in the second quarter of 2019. The results were impacted by lower sales volumes, lower average TiO2 selling prices, and higher raw materials and production costs, compounded by the COVID-19 pandemic's effect on global demand.

Kronos Worldwide reported a decrease in net income to $27.0 million, or $.23 per share, compared to $30.3 million, or $.26 per share, in Q1 2019. Net sales also decreased to $421.0 million, a 4% decrease compared to Q1 2019, primarily due to lower sales volumes. The company noted that COVID-19 had limited impact on operations during the first quarter but expects lower sales and earnings for the remainder of 2020.

Kronos Worldwide's fourth quarter 2019 net sales increased by 7% compared to the fourth quarter of 2018, driven by higher sales volumes. However, net income decreased due to lower average selling prices and higher raw materials and production costs.